project id: TCGA-READ; case submitter id: TCGA-AG-3586; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.0; rna integrity number: 9.3; age at index: 72; days to birth: -26542; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1934; age at diagnosis: 26542; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 31.0; icd 10 code: C19; last known disease status: not reported; morphology: 8480/3; primary diagnosis: Mucinous adenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Rectosigmoid junction; synchronous malignancy: No; tissue or organ of origin: Rectosigmoid junction; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.8; longest dimension: 1.1; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-AG-3586-01A-02; percent stromal cells: 5.0;